Bills › 90th General Assembly

Where it is now

  1. Done: IntroducedJanuary 17, 2024
  2. Done: SubcommitteeJanuary 17, 2024
  3. Done: Senate committeeFebruary 14, 2024
  4. Skipped: Passes the SenateContinued as SF 2357
  5. Next: House committee
  6. Next: Passes the House
  7. Next: To the Governor
  8. Next: Signed into law

Became SF 2357 → Its progress continues under the new number. Go to SF 2357 What’s a funnel?

What’s in it

This bill relates to the regulation of pharmacy benefits managers (PBMs). Under current law, a PBM owes a duty of good faith and fair dealing to third-party payors. The bill expands that duty to pharmacies. The bill prohibits retaliation by a PBM against a pharmacy based on the pharmacy’s exercise of any right or remedy, or on the pharmacy’s cooperation with the commissioner. Prohibited retaliation includes terminating or refusing to renew a contract with a pharmacy, subjecting a pharmacy to increased audits, or withholding or failing to promptly pay the pharmacy any money owed by the PBM.

Read the full explanation

Current law prohibits a PBM from assessing, charging, or collecting any form of renumeration that passes from a pharmacist in a pharmacy network to the PBM. Under the bill, a PBM is prohibited from assessing, charging, or collecting any form of renumeration that passes from any pharmacist, regardless of whether the pharmacist is in a pharmacy network. Under current law, for each maximum allowable cost list that a PBM uses, a PBM shall update the maximum allowable cost list within seven days from the date of an increase of percent or more in the pharmacy acquisition cost of a prescription drug on the list. _____ list that a PBM uses, a PBM shall update the maximum allowable cost list within seven days from the date of an increase of percent or more in the national average drug acquisition cost of a prescription drug on the list. The bill requires that the annual report provided by a PBM to the commissioner of insurance regarding prescription drug benefits provided to covered persons of each third-party payor with whom the PBM has contracted during the prior calendar year be in a format that does not publicly disclose the identity of a specific third-party payor, the price charged by a specific pharmaceutical manufacturer for prescription drugs, or the amount of rebates provided for prescription drugs.

Full bill text · What changed before it passed1

Senate subcommittee

Named January 17, 2024. On January 23, 2024 it recommended amendment and passage. [].

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Iowa Code it changes

Creates§510B.4A

Amends§510B.1§510B.4§510B.7§510B.8A§510C.2

How the Code works2

Lobbying

6 for · 0 against · 27 undecided · Who →

Family tree